Cytotoxic effects of 1α,25-dihydroxyvitamin D3 and synthetic vitamin D3 analogues on a glioma cell line

Cancer Letters

Volumn 100, Issue 1-2, 1996, Pages 3-10

  Baudet, Christel ^a   Chevalier, Guillemette ^a   Naveilhan, Philippe ^a   Binderup, Lise ^b   Brachet, Philippe ^a   Wion, Didier ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b LEO PHARMA A S   (Denmark)

Author keywords

c myc; DNA fragmentation; Glioma; Vitamin D3

Indexed keywords

20 EPI 22 ETHOXY 24A,26A,27A TRIHOMO 9,10 SECOCHOLESTA 5,7,10(19) TRIEN 23 YNE 1ALPHA,3BETA,25 TRIOL; CALCIPOTRIOL; CALCITRIOL; DNA FRAGMENT; LEXACALCITOL; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG POTENCY; GENE INDUCTION; GLIOMA CELL; HYPERCALCEMIA; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PSORIASIS; RAT;

EID: 0029670714     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(95)04054-4     Document Type: Article

References (31)

1. Ushio, Y. (1991) Treatment of glioma in adults. Curr. Opin. Oncol., 3, 467-475.
2. Weingart, J. and Brem, H. (1992) Biology and therapy of glial tumors. Curr. Opin Neurol. Neurosurg., 5, 808-812.
3. Merchant, R.E., McVicar, D.W., Merchant, L.H. and Young, H.F. (1992) Treatment of recurrent malignant glioma by repeated intracerebral injections of human interleukin-2 alone or in combination with systemic interferon-α. Results of a phase I clinical trial. J. Neuro-Oncol., 12, 75-83.
4. Holladay, F.P., Heitz, T., Chen, Y.L., Chiga, M. and Wood, G.W. (1992) Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes. Neurosurgery, 31, 528-533.
5. Trojan, J., Johnson, T.R., Rudin, S.D., Ilan, J., Tykocinski, M.L. and Ilan, J. (1993) Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science, 259, 94-97.
6. Culver, K.W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E.H. and Blaese, R.M. (1992) In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumor. Science, 256, 1550-1552.
7. DeLuca, H.F. and Ostrem, V. (1986) The relationship between the vitamin D system and cancer. Adv. Exp. Med. Biol., 206, 413-429.
8. Reichel, H., Koeffler, H.P. and Norman, A.W. (1989) The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med., 320, 980-991.
9. Pols, H.A.P., Birkenhager, J.C., Foekens, J.A. and Leeuwen, P.T.M. (1990) Vitamin D: a modulator of cell proliferation and differentiation. J. Steroid Biochem. Mol. Biol., 6, 873-876.
10. 3: towards an endocrine therapy of brain tumors? J. Neurosci. Res., 37, 271-277.
11. Binderup, L. and Bramm, E. (1988) Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem. Pharmacol., 37, 889-895.
12. Binderup, L., Latini, S. and Kissmeyer, A.-M. (1991) New vitamin D3 analogues with potent effects on cell growth regulation and immune response: structure-activity studies. In: Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical Applications: Proc. 8th Workshop on Vitamin D, Paris, France, pp. 478-485. Editors: A.W. Norman et al. de Gruyter, Berlin.
13. Calverley, M.J., Grue-Sorensen, G., Bretting, C. and Binderup, L. (1994) Chemistry and biology of highly active 22-oxy analogs of 20-epi calcitriol with very low binding affinity to the vitamin D receptor. In: Vitamin D: a Pluripotent Steroid Hormone. Structural Studies, Molecular Endocrinology and Clinical Applications: Proc. 9th Workshop on Vitamin D, Orlando, FL, pp. 85-86. Editors: A.W. Norman et al. de Gruyter, Berlin.
14. Benda, P., Lightobody, J., Sato, G., Levine, L. and Sweet, W. (1968) Differentiated rat glial cell strain in culture. Science, 161, 370-371.
15. Mallorga, P., Tallman, J.F., Vuillemin, J. and Fishman, P.H. (1981) Differences in the β-adrenergic responsiveness between high and low passage rat glioma C6 cells. Biochim. Biophys. Acta, 678, 221-229.
16. Bohn, W., Röser, K., Hohenberg, H., Mannweiler, K. and Traub, P. (1993) Cytoskeleton architecture of C6 rat glioma cell subclones differing in intermediate filament protein expression. J. Struct. Biol., 111, 48-58.
17. Gubits, R.M., Yu, H., Casey, G., Munell, F. and Vitek, M.P. (1992) Altered genetic response to β-adrenergic receptor activation in late passage C6 glioma cells. J. Neurosci. Res., 33, 297-305.
18. Jordan, J.P., Hand, C.M., Markowitz, R.S. and Black, P. (1992) Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. J. Neuro-Oncol., 14, 19-35.
19. Auffray, C. and Rougeon, F. (1980) Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem., 107, 303-314.
20. Wion, D., MacGrogan, D., Neveu, I., Jehan, F., Houlgatte, R. and Brachet, P. (1991) 1,25-dihydroxyvitaminD3 is a potent inducer of nerve growth factor synthesis. J. Neurosci. Res., 28, 110-114.
21. Fort, P., Piechaczyk, M., Sabrouty, S., Dani, C., Jeanteur, P. and Blanchard, J.-M. (1985) Various rat adult tissues express only one major mRNA species from glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res., 13, 1431-1442.
22. Smith, C.A., Williams, G.T, Kingston, R., Jenkinson, E.J., Cros, C. and Owen, J.J.T. (1989) Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature, 337, 181-184.
23. Veyron, P., Pamphile, R., Binderup, L. and Touraine J.-L. (1993) Two novel vitamin D analogues, KH 1060 and CB 966, prolong skin allograft survival in mice. Transpl. Immunol., 1, 72-76.
24. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, K. and Waters, C.M. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
25. Shi, Y., Glynn, J.M., Guilbert, L.J., Cotter, T.G., Bissonnette, R.P. and Green, D.R. (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridoma. Science, 257, 212-214.
26. Wyllie, A.H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease. Nature, 284, 555-556.
27. Colston, K.W., Mackay, A.G., James, S.Y., Binderup, L., Chander, S. and Coombes. R.C. (1992) EB 1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem. Pharmacol., 44, 2273-2280.
28. Bower, M., Colston, R.C., Stein, R.C., Hedley, A., Gazet, J.C., Ford, H.T. and Coombes, R.C. (1991) Topical calcipotriol treatment in advanced breast cancer. Lancet, 337, 701-702.
29. Kragballe, K., Gjertsen, B.T., DeHoop, D., Karlsmark, T., van De Kerkof, P.C.M., Larko, O., Tikjob, G., Nieboer, C., Strand, A. and Roed-Petersen, J. (1991) Double blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet, 337, 193-196.
30. 3H) 1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am. J. Physiol., 244, E266-E271.
31. Pardrige, W.M., Sakiyama, R. and Coty, W.A. (1985) Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J. Neurochem., 44, 1138-1141.